ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988